|
AMZN
|
Consumer Cyclical |
KeyBanc Capital Markets |
Maintains
|
Overweight
→
Overweight
|
—
|
$2.9T
|
$244.68
|
+0.7%
|
-0.7%
|
-0.5%
|
-1.0%
|
+1.5%
|
-1.8%
|
|
AMZN
|
Consumer Cyclical |
Oppenheimer |
Maintains
|
Outperform
→
Outperform
|
—
|
$2.9T
|
$244.68
|
+0.7%
|
-0.7%
|
-0.5%
|
-1.0%
|
+1.5%
|
-1.8%
|
|
XOM
|
Energy |
BofA Securities |
Maintains
|
Neutral
→
Neutral
|
—
|
$609.1B
|
$136.83
|
+0.6%
|
+0.5%
|
+2.1%
|
+0.6%
|
-2.1%
|
+3.9%
|
|
JNJ
|
Healthcare |
Morgan Stanley |
Upgrade
|
Equal Weight
→
Overweight
|
—
|
$535.5B
|
$224.44
|
+0.9%
|
+1.5%
|
-0.2%
|
-0.0%
|
+1.5%
|
+1.0%
|
|
UNH
|
Healthcare |
Jefferies |
Maintains
|
Buy
→
Buy
|
—
|
$335.5B
|
$282.70
|
+0.4%
|
+4.0%
|
-0.6%
|
-1.8%
|
-0.5%
|
-0.5%
|
|
UNH
|
Healthcare |
UBS |
Maintains
|
Buy
→
Buy
|
—
|
$335.5B
|
$282.70
|
+0.4%
|
+4.0%
|
-0.6%
|
-1.8%
|
-0.5%
|
-0.5%
|
|
UNH
|
Healthcare |
Oppenheimer |
Maintains
|
Outperform
→
Outperform
|
—
|
$335.5B
|
$282.70
|
+0.4%
|
+4.0%
|
-0.6%
|
-1.8%
|
-0.5%
|
-0.5%
|
|
UNH
|
Healthcare |
Leerink Partners |
Maintains
|
Outperform
→
Outperform
|
—
|
$335.5B
|
$282.70
|
+0.4%
|
+4.0%
|
-0.6%
|
-1.8%
|
-0.5%
|
-0.5%
|
|
UNH
|
Healthcare |
RBC Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$335.5B
|
$282.70
|
+0.4%
|
+4.0%
|
-0.6%
|
-1.8%
|
-0.5%
|
-0.5%
|
|
AMAT
|
Technology |
Mizuho |
Upgrade
|
Neutral
→
Outperform
|
—
|
$325.8B
|
$332.71
|
+2.8%
|
+1.2%
|
+1.4%
|
-5.6%
|
+1.9%
|
-3.0%
|
|
TXN
|
Technology |
Stifel |
Maintains
|
Hold
→
Hold
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
TXN
|
Technology |
Benchmark |
Maintains
|
Buy
→
Buy
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
TXN
|
Technology |
Deutsche Bank |
Maintains
|
Hold
→
Hold
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
TXN
|
Technology |
UBS |
Maintains
|
Buy
→
Buy
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
TXN
|
Technology |
Goldman Sachs |
Maintains
|
Sell
→
Sell
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
TXN
|
Technology |
Cantor Fitzgerald |
Maintains
|
Neutral
→
Neutral
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
TXN
|
Technology |
BofA Securities |
Upgrade
|
Underperform
→
Neutral
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
TXN
|
Technology |
Wells Fargo |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
TXN
|
Technology |
Rosenblatt |
Maintains
|
Buy
→
Buy
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
TXN
|
Technology |
KeyBanc Capital Markets |
Maintains
|
Overweight
→
Overweight
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
TXN
|
Technology |
Truist |
Maintains
|
Hold
→
Hold
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
TXN
|
Technology |
Jefferies |
Maintains
|
Hold
→
Hold
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
TXN
|
Technology |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
TXN
|
Technology |
Mizuho |
Maintains
|
Underperform
→
Underperform
|
—
|
$259.5B
|
$196.63
|
+3.7%
|
+9.9%
|
+1.3%
|
-1.6%
|
+4.4%
|
+0.1%
|
|
RTX
|
Industrials |
UBS |
Maintains
|
Neutral
→
Neutral
|
—
|
$238.1B
|
$201.28
|
+0.0%
|
-0.9%
|
+0.2%
|
+0.5%
|
+0.1%
|
+1.2%
|
|
RTX
|
Industrials |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$238.1B
|
$201.28
|
+0.0%
|
-0.9%
|
+0.2%
|
+0.5%
|
+0.1%
|
+1.2%
|
|
RTX
|
Industrials |
RBC Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$238.1B
|
$201.28
|
+0.0%
|
-0.9%
|
+0.2%
|
+0.5%
|
+0.1%
|
+1.2%
|
|
NEE
|
Utilities |
Argus |
Maintains
|
Buy
→
Buy
|
—
|
$194.6B
|
$87.15
|
+0.7%
|
+0.5%
|
+0.7%
|
-0.3%
|
-1.8%
|
+2.9%
|
|
NEE
|
Utilities |
Mizuho |
Maintains
|
Neutral
→
Neutral
|
—
|
$194.6B
|
$87.15
|
+0.7%
|
+0.5%
|
+0.7%
|
-0.3%
|
-1.8%
|
+2.9%
|
|
BA
|
Industrials |
Citigroup |
Maintains
|
Buy
→
Buy
|
—
|
$182.1B
|
$244.56
|
-0.2%
|
-1.2%
|
-3.1%
|
-0.1%
|
-0.3%
|
+0.1%
|
|
BA
|
Industrials |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$182.1B
|
$244.56
|
-0.2%
|
-1.2%
|
-3.1%
|
-0.1%
|
-0.3%
|
+0.1%
|
|
BA
|
Industrials |
RBC Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$182.1B
|
$244.56
|
-0.2%
|
-1.2%
|
-3.1%
|
-0.1%
|
-0.3%
|
+0.1%
|
|
BA
|
Industrials |
UBS |
Maintains
|
Buy
→
Buy
|
—
|
$182.1B
|
$244.56
|
-0.2%
|
-1.2%
|
-3.1%
|
-0.1%
|
-0.3%
|
+0.1%
|
|
STX
|
Technology |
Goldman Sachs |
Maintains
|
Buy
→
Buy
|
—
|
$171.8B
|
$371.76
|
+6.3%
|
+19.1%
|
+0.8%
|
-8.7%
|
+6.2%
|
+2.7%
|
|
STX
|
Technology |
Wells Fargo |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$171.8B
|
$371.76
|
+6.3%
|
+19.1%
|
+0.8%
|
-8.7%
|
+6.2%
|
+2.7%
|
|
STX
|
Technology |
Barclays |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$171.8B
|
$371.76
|
+6.3%
|
+19.1%
|
+0.8%
|
-8.7%
|
+6.2%
|
+2.7%
|
|
STX
|
Technology |
UBS |
Maintains
|
Neutral
→
Neutral
|
—
|
$171.8B
|
$371.76
|
+6.3%
|
+19.1%
|
+0.8%
|
-8.7%
|
+6.2%
|
+2.7%
|
|
STX
|
Technology |
Mizuho |
Maintains
|
Outperform
→
Outperform
|
—
|
$171.8B
|
$371.76
|
+6.3%
|
+19.1%
|
+0.8%
|
-8.7%
|
+6.2%
|
+2.7%
|
|
STX
|
Technology |
Rosenblatt |
Maintains
|
Buy
→
Buy
|
—
|
$171.8B
|
$371.76
|
+6.3%
|
+19.1%
|
+0.8%
|
-8.7%
|
+6.2%
|
+2.7%
|
|
STX
|
Technology |
Cantor Fitzgerald |
Maintains
|
Overweight
→
Overweight
|
—
|
$171.8B
|
$371.76
|
+6.3%
|
+19.1%
|
+0.8%
|
-8.7%
|
+6.2%
|
+2.7%
|
|
UNP
|
Industrials |
Citigroup |
Maintains
|
Buy
→
Buy
|
—
|
$157.2B
|
$232.55
|
-0.3%
|
-2.1%
|
+2.6%
|
+0.7%
|
+0.1%
|
+2.7%
|
|
UNP
|
Industrials |
JP Morgan |
Maintains
|
Neutral
→
Neutral
|
—
|
$157.2B
|
$232.55
|
-0.3%
|
-2.1%
|
+2.6%
|
+0.7%
|
+0.1%
|
+2.7%
|
|
GLW
|
Technology |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$156.7B
|
$109.74
|
-1.7%
|
-5.0%
|
-1.2%
|
+0.2%
|
+6.9%
|
+2.2%
|
|
PANW
|
Technology |
Needham |
Maintains
|
Buy
→
Buy
|
—
|
$133.9B
|
$183.50
|
+0.6%
|
+0.1%
|
-4.1%
|
+0.4%
|
-0.9%
|
-5.2%
|
|
BMY
|
Healthcare |
Piper Sandler |
Maintains
|
Overweight
→
Overweight
|
—
|
$114.8B
|
$55.56
|
-1.0%
|
-1.7%
|
-0.6%
|
+1.4%
|
+1.5%
|
+0.2%
|
|
CVS
|
Healthcare |
Argus |
Maintains
|
Buy
→
Buy
|
—
|
$111.4B
|
$72.00
|
-0.5%
|
+2.8%
|
+0.6%
|
+0.1%
|
+1.2%
|
+1.9%
|
|
VRTX
|
Healthcare |
Barclays |
Upgrade
|
Equal Weight
→
Overweight
|
—
|
$107.8B
|
$474.17
|
-0.0%
|
+0.8%
|
-0.5%
|
-1.2%
|
+0.4%
|
-1.4%
|
|
HCA
|
Healthcare |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$95.2B
|
$505.84
|
-1.2%
|
-2.9%
|
-1.8%
|
+1.2%
|
+1.8%
|
+0.5%
|
|
HCA
|
Healthcare |
RBC Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$95.2B
|
$505.84
|
-1.2%
|
-2.9%
|
-1.8%
|
+1.2%
|
+1.8%
|
+0.5%
|
|
HCA
|
Healthcare |
Jefferies |
Maintains
|
Buy
→
Buy
|
—
|
$95.2B
|
$505.84
|
-1.2%
|
-2.9%
|
-1.8%
|
+1.2%
|
+1.8%
|
+0.5%
|